Immunomedics, Inc.
(NASDAQ : IMMU)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.24%72.280.9%$621.14m
CELGCelgene Corporation
0.02%127.681.1%$445.44m
AMGNAmgen Inc.
0.20%167.621.1%$419.30m
BIIBBiogen Inc.
0.19%282.311.2%$357.06m
REGNRegeneron Pharmaceuticals, Inc.
0.19%468.892.7%$322.46m
VRTXVertex Pharmaceuticals Incorporated
0.48%148.841.9%$265.87m
ALXNAlexion Pharmaceuticals, Inc.
0.82%134.491.9%$219.75m
ILMNIllumina, Inc.
0.42%190.123.5%$217.26m
SRPTSarepta Therapeutics, Inc.
0.33%36.8219.8%$138.90m
INCYIncyte Corporation
-1.21%119.722.6%$129.36m
CLVSClovis Oncology, Inc.
-0.75%71.4218.0%$128.23m
KITEKite Pharma, Inc.
1.32%131.9016.1%$123.45m
TSROTESARO, Inc.
-0.21%113.6314.7%$121.44m
AAgilent Technologies, Inc.
0.51%61.561.5%$119.63m
BMRNBioMarin Pharmaceutical Inc.
0.09%80.994.4%$108.67m

Company Profile

Immunomedics, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products. The company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. It markets and sells its products in the U.S. and throughout Europe. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.